Medtric

Medtric, founded with a mission to revolutionize wound care, focuses on delivering clinically robust and economically sensible solutions. Leveraging innovative nanoscale technology, Medtric aims to advance patient care by preventing infections and promoting healing. Their flagship technology, developed in collaboration with leading research and medical institutions, is designed to protect wounds against infection. Medtric's market focus spans healthcare, industrial, and agricultural applications.

Notable affiliated individuals include researchers and medical professionals from top institutions who contributed to the development of Medtric's technology. The company has received investment from key stakeholders in the healthcare and biotech sectors. Medtric's achievements include the successful commercialization of their nanoscale-based therapy, which has made a significant impact on reducing infection rates and improving patient outcomes. Their work addresses critical challenges in antimicrobial resistance, benefiting both the healthcare system and patients globally.